Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?


Bozkaya Y., Ozdemir N. Y. , Sezer S., Kostek O., Demirci N. S. , Yazici O., ...More

CANCER BIOMARKERS, vol.22, no.1, pp.143-149, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 1
  • Publication Date: 2018
  • Doi Number: 10.3233/cbm-171119
  • Journal Name: CANCER BIOMARKERS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.143-149
  • Keywords: Modified DCF, locally advanced gastric cancer, neoadjuvant chemotherapy, survivin, predictive, ANTI-APOPTOSIS GENE, MESSENGER-RNA, FAVORABLE PROGNOSIS, CISPLATIN TREATMENT, ESOPHAGEAL CANCER, POTENTIAL ROLE, ASSOCIATION, CARCINOMA, THERAPY, PROLIFERATION
  • Gazi University Affiliated: Yes

Abstract

BACKGROUND: The potential prognostic value of survivin is variably reported depending on the gastric cancer.